References
- Senior J. Fate and behavior of liposomes in vivo: a review of controlling factors. CRC Crit Rev Ther Drug Carrier Syst 1987; 3: 123–193
- Gabizon A, Papahadjopoulos D. The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim Biophys Acta 1992; 1103: 94–100
- Woodle M C, Lasic D D. Sterically stabilized liposomes. Biochim Biophys Acta 1992; 1113: 171–199
- Gabizon A. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 1992; 52: 891–896
- Druckmann S, Gabizon A, Barenholz Y. Separation of liposome-associated doxorubicin from nonliposome-associated doxorubicin in human plasma:implications for pharmacokinetic studies. Biochim Biophys Acta 1989; 980: 381–384
- Gabizon A, Shiota R, Papahadjopoulos D. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J Natl Cancer Inst 1989; 81: 1484–1488
- Horowitz A T, Barenholz Y, Gabizon A. In vitro cytotoxicity of liposome-encapsulated doxorubicin: Dependence on liposome composition and drug release. Biochim Biophys Acta 1992; 1109: 203–209
- Papahdjopoulos D, Allen T, Gabizon A, Mayhew E, Matthay K, Huang S K, Lee K D, Woodle M C, Lasic D D, Redemann C, Martin F J. Sterically stabilized liposomes: Improvements in pharmacokinetics and anti-tumor therapeutic efficacy. Proc Natl Acad Sci USA 1991; 88: 11460–11464
- Gabizon A, Barenholz Y, Bialer M. Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: Pharmacokinetic studies in rodents and dogs. Pharm Res 1993; 10: 703–708
- Mayhew E, Lasic D D, Babbar S, Martin F J. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. Int J Cancer 1992; 51: 302–309
- Vaage J, Mayhew E, Lasic D D, Martin F. Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes. Int J Cancer 1992; 51: 942–948
- Huang S K, Mayhew E, Gilani S, Lasic D D, Martin F J, Papahadjopoulos D. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res 1992; 52: 6774–6781
- Forssen E A, Tokes Z A. Attenuation of dermal toxicity of doxorubicin by liposome encapsulation. Cancer Treat Rep 1983; 67: 481–484
- Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Barenholz Y, Huang A. Pharmacokinetics of doxorubicin encapsulated in StealthR liposomes in cancer patients (Abstract). Ann. Oncol. 1992; 3(Supp. 1)140